Bausch & Lomb has ordered a permanent worldwide retraction of its ReNu with MoistureLoc solution, which continues to be under investigation by the U.S. Federal Drug Administration on suspicion that it has been connected with a recent outbreak of an eye disease, Fusarium keratitis. The solution generated about $100 million ...
Buying a membership today will give you:
To continue reading this article register now.